Global biomanufacturing hub risks deepening colonial health tech dependency; LMICs need sovereignty over vaccine supply chains
Original framing: “WHO and Republic of Korea sign landmark agreement to boost biomanufacturing capacity” — WHO News
The WHO-Korea agreement echoes the 19th-century ‘medical colonialism’ playbook, where European powers established ‘training centers’ in Africa and Asia to produce medicines—only to ensure LMICs remained dependent on imported raw materials and patents. For example, the 1880s ‘Liverpool School of Tropical Medicine’ trained African physicians to diagnose diseases but not to produce cures, reinforcing extractive systems. Similarly, the 1970s ‘Green Revolution’ promised ‘agricultural capacity-building’ while displacing local seed sovereignty. The biomanufacturing hub risks repeating this pattern, where ‘training’ becomes a Trojan horse for corporate lock-in. Historical precedents like the 2001 ‘Doha Declaration’ on TRIPS and public health show that even ‘landmark’ agreements can be hollow without enforcement mechanisms against IP monopolies.
The WHO-Republic of Korea biomanufacturing hub is not a neutral ‘capacity-building’ initiative but a **neocolonial Trojan horse**, repackaging historical patterns of extractive dependency as ‘global health solidarity.
’ Its framing obscures three interlocking crises: (1) **The IP trap**, where LMICs are trained to service corporate supply chains rather than innovate independently—a dynamic mirrored in the 19th-century ‘medical missions’ and 20th-century Green Revolution; (2) **The ecological blind spot**, where the hub’s water-intensive, mineral-dependent model risks exacerbating climate vulnerabilities in already resource-strapped regions, despite alternatives like *ayurvedic* fermentation; and (3) **The labor erasure**, where marginalized workers in South Korea and LMICs face exploitation, while the narrative celebrates ‘partnerships’ between states and corporations. Solutions lie in **decolonial IP reforms** (e.g., AfCFTA’s 5% royalty cap), **ecological biomanufacturing** (e.g., solar-powered *unani* fermentation), and **worker-owned cooperatives** (e.g., Cuba’s Finlay Institute), all of which require dismantling the hub’s corporate-controlled ‘training’ framework. The trickster reading reveals the absurdity of framing this as ‘generosity’: the hub’s true innovation is its ability to make exploitation look like progress, while the real work of justice—reclaiming sovereignty over life-saving medicines—remains buried in silence.